Invest in Gene Editing or Synthetic Biology?
April 1, 2016The big news this past week was something so significant and remarkable that it should have been the topic of conversation at every water cooler… Read More
Intrexon
7 Synthetic Biology Companies to Invest In
September 4, 2015When it comes to promising disruptive technologies, synthetic biology has to be in the top-5. The ability… Read More
Intrexon’s Genetically Modified Insect Acquisition
August 12, 2015We’ve written quite a few articles about synthetic biology stock Intrexon (… Read More
What to do with your Ziopharm (ZIOP) shares
May 12, 2015We have published quite a few articles about Intrexon (NYSE:XON) since their… Read More
Intrexon Aquires an Arctic Apple That Doesn’t Brown
March 26, 2015We’ve written about Intrexon (NYSE:XON) before, a synthetic… Read More
Intrexon Acquires Therapeutic Protein Biofactories
February 16, 2015Synthetic biology, while perhaps a bit controversial, is truly an exciting field. In past articles, we’ve highlighted… Read More
Intrexon Can Now Clone Your Pet
October 24, 2014Just over a year ago, we wrote an article about a synthetic biology company,… Read More
Intrexon Bets on Lantibiotics with Oragenics
October 2, 2013In earlier articles we discussed synthetic biology and the… Read More
Skin Rejuvenation from Fibrocell (FCSC)
September 30, 2013In an earlier post titled “A Strong Synthetic Biology IPO by Intrexon“, we discussed… Read More
A Strong Synthetic Biology IPO by Intrexon
September 3, 2013In an earlier article titled “What is synthetic biology” we discussed the promising future of a disruptive… Read More